Hot Investor Mandate 2: Hong Kong VC Seeks DNA Diagnostics

21 Jul

A venture capital firm based in Hong Kong makes seed and early stage investments across several sectors including the life sciences. The firm typically allocates USD 75K to 500K per company as well as possible continuation into Series A. The firm can invest globally and is actively seeking new investment opportunities.

In the life sciences, the firm is interested in DNA genetic testing. For example, technologies such as pre-natal testing and DNA testing for oncology screening. The firm is also interested in and health & wellness technology for preventive care or management of chronic illness such as diabetes. The firm will focus on startups that have already gained some traction. The firm historically invested in molecular diagnostics and DNA screening.

The firm looks to partner with exceptional entrepreneurs and generally looks to take a board seat post investment, though this is not a requirement.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: